Accelerate Diagnostics (Accelerate Diagnostics) GF Value Rank : 2 (As of May. 17, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Accelerate Diagnostics GF Value Rank?

Accelerate Diagnostics has the GF Value Rank of 2.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Accelerate Diagnostics's GF Value Rank

For the Medical Devices subindustry, Accelerate Diagnostics's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerate Diagnostics's GF Value Rank Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's GF Value Rank falls into.

Accelerate Diagnostics GF Value Rank Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerate Diagnostics (Accelerate Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (NAS:AXDX) » Definitions » GF Value Rank

Comparable Companies

Traded in Other Exchanges

AXDX:Mexico 1A80:Germany

Address

3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714

Website

https://www.acceleratediagnostics.com

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Executives

David Patience	officer: Chief Financial Officer	C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 240, TUCSON AZ 85714
Jack Phillips	director, officer: PRESIDENT AND CEO	11731 YALE DR, CARMEL IN 46032
Larry Michael Mertz	officer: Chief Technology Officer	3950 S. COUNTRY CLUB ROAD, TUCSON AZ 85714
Marran H. Ogilvie	director	599 LEXINGTON AVENUE, NEW YORK NY 10022
Jennifer Regan	director	C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON AZ 85714
Mark S. Black	director	3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON AZ 85714
Steven Reichling	officer: CFO	7000 NORTH BROADWAY, BUILDING 3-307, DENVER CO 80221
Ron Price	officer: SVP & HEAD OF COM OPS AMERICAS	3950 SOUTH COUNTRY CLUB ROAD, SUITE 470, TUCSON AZ 85714
Wayne Burris	director	3451 PLANO PARKWAY, LEWISVILLE TX 75056
Hany Massarany	director	1910 INNOVATION PARK DR, TUCSON AZ 85737
Jack W Schuler	director, 10 percent owner	100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Mark C Miller	director	C/O STERICYCLE INC., 28161 N KEITH DRIVE, LAKE FOREST IL 60045
Ten Brink Frank Jm	director	C/O STERICYCLE INC, 28161 N KEITH DR, LAKE FOREST IL 60045
Charles M Watts	director	3950 SOUTH COUNTRY CLUB, SUITE 470, TUCSON AZ 85714
Louise Francesconi	director	870 WINTER STREET, WALTHAM MA 02451